最新数据，请关注
微信公众号: GS_2468 
| 名称 | 广西玉林制药集团有限责任公司 |
| name | GUANGXI YULIN PHARMACEUTICAL GROUP CO., LTD. |
| Contact Person | 党志林 |
| sex | male |
| Fax | pd2sdCaGknWD5VrzjxQW4A== |
| Tel | mjsNS5LzWEv1fCEPBTwUBg== |
| TcWW7Baw+ODV03ZDY5xBpiGp/pmxww4XO46qnyQ33xI= | |
| Mobile | DBP7eZ9G0FMLZkRGUGbEvg== |
| 手机运营商 | 电信 |
| 手机号码归属省份 | 广西 |
| 手机号码归属城市 | 玉林 |
| 产品 | 中成药 |
| products | Chinese traditional herbs |
| 简介 | 广西玉林制药创建于 1956 年，是商务部首批认定的“中华老字号”企业，为康臣药业集团（1681.HK）成员企业之一，专注于中成药和天然药物的研发、生产和销售；旗下拥有玉药胶囊有限公司、玉铭中药有限责任公司、永绿中药产业有限公司和宏升贸易有限公司等从事药用辅料生产、药材种植和药品交易的企业。半个多世纪以来，玉林制药秉承“承古拓新、良药济民”的企业使命，艰苦奋斗、改革创新，赢得了消费者及社会各界的广泛认可与赞誉，成功打造驰名中外的“玉林”品牌，品牌价值达19 亿。公司资产优良，经营稳健，各项经济指标连续15年保持两位数增长。2003年以广西玉林制药有限责任公司为母公司组建了广西玉林制药集团，到目前，集团共有成员单位9个，业务已扩展到中药材的种植与经营、中药饮片的加工、药用空心胶囊的制造、药用包装材料的生产经营及国内国际贸易等领域，集团产销规模达6亿多元。公司占地面积25万多平方米，现有员工1000多人，资产总额3亿元；拥有健全的质量保障体系，于1996年通过澳大利亚TGA的GMP认证并连续10次通过复查，2003年整体通过国家GMP认证；生产设备精良，技术力量雄厚，是广西较早建立区（省）级技术中心的企业之一，先后被认定为“广西现代中药工程技术研究中心”、“自治区级研发中心” 。2015 年8 月，康臣药业集团入主玉林制药，驱动“中华老字号”进入跨越发展的新时代。康臣玉林制药转制三年来，经营规模和纳税金额连创新高，实现三年翻一番，揭开第二个60 年的崭新篇章。厚重而年轻的玉林制药正散发出勃勃生机，朝着“多专科领先的一流中医药企业”奔腾向前。公司坚持以市场为导向，以项目为载体，加强产学研的联合，具有良好的产品研发能力及技术合作基础。先后与中国药科大学、天津药物研究院、广西中医药大学、广西民族医药研究所、广西药用植物园等著名高校和科研院所开展深度的产学研合作。康臣玉林制药拥有56 名高中级工程技术人员，18 位高级研究人才，20 多名研发型人才。2013 年5 月获广西壮族自治区科技厅批准设立“广西院士工作站”，中国工程院刘昌孝院士驻站指导研究工作，为公司中成药研究、开发提供强有力的人才保障。康臣玉林制药在广西玉林市拥有两个生产基地，两个生产基地共有23 条GMP 生产线，拥有强大的中药综合处理及制剂能力，其中胶囊剂17.5亿粒/年，片剂6.7亿片/年，酊剂76万升/年；产品有9个剂型70多个品种，其中国家中药保护品种有：正骨水、湿毒清胶囊、鸡骨草胶囊等十二个品种。产品质量可靠，疗效确切，市场信誉良好。公司在全国28 个省、市、自治区建立30 多个联络点，提供即时的市场推广服务；与全国近600 家商业客户建立长期、稳定的合作关系。公司具有自营进出口权，出口产品50种，远销28多个国家和地区，已在26 个国家和地区完成注册或正在办理注册。年出口创汇近300万美元。近年来，公司先后荣获：全国医药制药行业百强企业、全国中药行业设备管理先进单位、全国医药行业法制工作先进单位、全国医药系统先进集体等国家级荣誉称号，并连续多年被评为广西优秀企业、广西经济效益先进企业。康臣玉林制药以“一百道工序、一百个放心”的质量自律，企业的生产质量管理水平和国际接轨，生产中不断改进工艺，提高产品质量，应用国际先进的设备和技术，保证生产过程及产品质量稳定，致力制造高科技、高品质、高效能的产品。企业连续十次通过澳大利亚TGA 的GMP 认证，两次通过美国FDA 的GMP 现场检查，荣获玉林市市长质量奖，正骨水通过欧盟CE 认证，获得出口欧盟国家的免检资格。康臣玉林制药通过数十年积累，打造了涵盖骨科、皮肤科、肝胆科等治疗领域的强大产品组合，拥有 9 个剂型 73 个品种，其中 OTC 品种（含双跨）41 个，独家品种 19 个，地理标志产品 1 个，中药保护品种 13 个；国家医保品种25 个，国家基药品种 11 个。依托康臣药业集团，秉持 “承古拓新、良药济民”的使命，拥有60 年历史的老字号品牌康臣玉林制药已然走在时代前端，为成为“多专科领先的一流中医药企业”奔腾向前。为推动玉林市中医药健康产业集中式和集约式发展，康臣玉林制药将建设“自动化、智能化、信息化”三化融合的新工业园。未来，康臣玉林制药将充分发挥玉林中医药健康产业的区位价值和辐射能力，开启广西医药产业发展的新格局，更好的落实“健康中国”的国家战略，构筑中国医药的新版图，再造中国制药的新传奇。 |
| description | Founded in 1956, Guangxi Yulin Pharmaceutical Group is one of the first “China Time-honored Brand” enterprise certified by the Ministry of Commerce. It is one of the member companies of Consun Pharmaceutical Group (1681.HK), focusing on the research and development, production and sales of Chinese patent medicines and natural medicines. It has subsidiaries which are engaged in the production of pharmaceutical excipients, herbs plantation and drug trading, such as Guangxi Yulin Yuyao Capsule Co., Ltd., Yuming Chinese Medicine Co., Ltd., Yonglv Chinese Medicine Industry Co., Ltd. and Hongsheng Trading Co., Ltd. For more than half a century, Yulin Pharmaceutical has been adhering to the corporate mission of “making good medicines by inheriting & innovating to benefithuman”. By hard-working, reform and innovation, it has won wide recognition and praise from consumers and the society, and successfully built the Yulin Brand which is famous both at home and abroad, and our brand value has reached 1.9 billion yuan. The company has excellent assets and operates stably, and all economic indicators have kept growing by double digit for 15 consecutive years. In 2003, Guangxi Yulin Pharmaceutical Group was set up taking Guangxi Yulin Pharmaceutical Co., Ltd. as parent company. So far, the group has had 9 affiliates in processing of traditional Chinese medicines prepared in ready-to-use forms, manufacturing of medicinal hollow capsules, production and operation of medicinal packaging materials, domestic and foreign trades, etc. The group’s annual sales amount has exceeded RMB 600 million. The company covers a land area of more than 250,000m2, and now has more than 1000 employees and total assets of RMB 300 million. With perfect quality assurance system,the company passed Good Manufacturing Practice (GMP) certification of Australian Therapeutic Goods Administration (TGA) in 1996 and relevant rechecks for 10 consecutive times, and passed Chinese GMP certification as a whole in 2003. The company, earliest enterprises to establish an autonomous region level (provincial level) technology center in Guangxi, has fine production equipment, powerful technical strength. It has been identified as Guangxi Modern Chinese Medicine Engineering Technology Research Center and Autonomous Region-level R&D Center. In August 2015, Consun Pharmaceutical Group took control of Yulin Pharmaceutical and promoted the “China Time-honored Brand” into a new era of development. After the three years since the restructuring of Consun Yulin Pharmaceutical, the scale of operation and the amount of tax payment have reached new highs, achieving a three-year doubling and unveiling a new chapter in the second 60 years. The old while young Yulin Pharmaceutical is booming and moving forward toward the leading Chinese medicine companies that are specialized in the multiple fields. The company takes the market as the orientation and project as the carrier to strengthen the combination of production, education and research, and lay a good foundation for product research and development and technical cooperation. It has conducted in-depth cooperation in production, education and research with famous universities and research institutes such as China Pharmaceutical University, Tianjin Pharmaceutical Research Institute, Guangxi University of Traditional Chinese Medicine, Guangxi Institute of Minority Medicine, and Guangxi Medicinal Herb Garden. Consun Yulin Pharmaceutical has 56 high and midlevel engineering and technical personnel, 18 senior research personnel and more than 20 research and development personnel. In May 2013, Guangxi Academician Workstation was established through the approval by Guangxi Science and Technology Department. The Academician of the Chinese Academy of Engineering Liu Changxiao was in charge of the research works, providing a strong talent guarantee for the research and development of Chinese patent medicines. Consun Yulin Pharmaceutical has two production bases in Yulin, Guangxi province. The two production bases have a total of 23 GMP production lines, with strong capabilities of processingmedicinal materials and making preparations, including 1.75 billion pills, 670 million tablets and 760,000 liters of tincture per year. Our products are in 9 dosage forms and over 70 varieties, inclusive of 12 national protected TCM varieties such as Bone-setting Liquor, Shiduqing Capsule and Chiken-bone Herb Capsule. All products have reliable quality, definite effect and good fame on the market. The company has established more than 30 contact points in 28 provinces, municipalities and autonomous regions across the country to provide instant marketing services; established long-term and stable cooperative relations with nearly 600 commercial customers nationwide. With independent import and export rights, the company exports 50 kinds of products to over 28 countries and regions, the products have been registered or are being registered in 26 countries and regions. And earns foreign currency of nearly USD 3 million from export a year. In recent years, the company has won One of China Top 100 Medicine and Pharmacy Enterprises, National Advance Unit of Equipment Management in TCM Industry, National Advanced Unit of Legal Work in Medicine Industry, National Advanced Collectivity of Medicine Sector and other national honorable titles in sequence, and has been appraised as Excellent Enterprise of Guangxi and Advanced Enterprise of Economic Benefits of Guangxi for multiple consecutive years. Consun Yulin Pharmaceutical takes the principle of “One Hundred Processes and One HundredAssurance” to ensure high quality, improves the production, quality and management level of the enterprise to reach international standards, continuously improves the production processes, improves product quality, applies international leading equipment and technologies, ensures the stable production process and product quality, and tries to produce high-tech, high-quality, high-performance products. The enterprise has passed the GMP certification of Australian TGA for ten consecutive times, and passed twice of the GMP on-site inspection of US FDA. It was awarded Yulin Mayor Quality Award. Zhenggushui passed the EU CE certification and obtained the exemption qualification for exporting EU countries. Over decades of accumulation, Consun Yulin Pharmaceutical has established a strong product portfolio covering the fields of orthopedics, dermatology, hepatobiliary and other therapeutic fields, with 73 varieties of 9 dosage forms, including 41 OTC varieties, 19 exclusive varieties, 1 geographical indication product, 13 Chinese medicine protection varieties, 25 national medical insurance varieties, and 11 national basic medicine varieties. Relying on Consun Pharmaceutical Group, and adhering to the mission of “making good medicines by inheriting & innovating to benefit human”, the 60-year-old “time-honored brand” Consun Yulin Pharmaceutical has developed as a leading multi-disciplinary Chinese medicine company. In order to promote the centralized and intensive development of the traditional Chinese medicine health industry in Yulin City, Consun Yulin Pharmaceutical will build a new industrial park integrating automation, intelligence and informationization. In the future, Consun Yulin Pharmaceutical will give full play to the location value and radiation capacity of Yulin Chinese medicine health industry, initiate a new development pattern of Guangxi pharmaceutical industry, better implement the national strategy of Healthy China, build a new map of Chinese medicine, and re-create a new legend in Chinese pharmaceutical industry.In the future, Consun Yulin Pharmaceutical will give full play to the location value and radiation capacity of Yulin Chinese medicine health industry, initiate a new development pattern of Guangxi pharmaceutical industry, better implement the national strategy of Healthy China, build a new map of Chinese medicine, and re-create a new legend in Chinese pharmaceutical industry. |
| 大类 | 医药及医疗保健 |
| 小类 | 医药保健品及医疗器械 |
| 规模 | 500人以上 |
| 成立年份 | 1956 |
| 注册资金 | 14883 |
| 企业类型 | 生产企业 |
| 营业执照 | |
| 公司环境 | http://1300585764.vod2.myqcloud.com/8fdbfa69vodcq1300585764/d8f5710a5285890804117555930/f0.mp4?t=60c62614&sign=80b8a8cc7c031c4f14d64b221c9ed251 |
| 地区 | 中国 广西 |
| 地址 | 中国广西玉林市城站路1号 |
| 邮编 | 537001 |
| 官网 | http://www.chinayulin.com |
最新数据，请关注
微信公众号: GS_2468
